ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

DCE Proposes AIDS-Cancer Registry For Funding Through $2 Mil. Contract

April 9, 1993

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

In Brief: Salmon Heads AACI, Owens President Elect; AMA Adds PDQ To Its Electronic Network

June 30, 1989

Children’s Memorial Hospital Receives $3 Million Endowment From Price Trust

May 28, 2010

Roswell Park’s Future “Bright” As Center Snares Leading Scientists, Hohn Says.

January 18, 2002

NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.

March 26, 2004